Poster Presentation ESA-SRB-ANZBMS 2024 in conjunction with ENSA

Building an endometriosis biobank for clinical research: a 12-month evaluation of the Julia Argyrou Endometriosis Centre at Epworth Biobank (#433)

Sarah Holdsworth-Carson 1 2 , Dilshara Samaranayake 2 , Julia Gregory 2 , Kate Tyson 2
  1. Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia
  2. Julia Argyrou Endometriosis Centre, Epworth HealthCare, Ease Melbourne, VIC, Australia

Research efforts towards improving our understanding of endometriosis are slow.  Relative to breast cancer, which demonstrates >489,000 citations in PubMed in the last 40 years, there are only 31,500 citations for endometriosis.  Biobanks are essential for increasing the scale of clinical research and progressing towards a cure for endometriosis.  The Julia Argyrou Endometriosis Centre at Epworth (JAECE) established its biobank (2023) with the aim of collecting comprehensive patient and surgical information, and a variety of biospecimens, to strengthen collaborative research. 

 

The JAECE Biobank was established as a single centre prospective study, recruiting patients aged ≥18 years, pre-menopausal, not pregnant/breastfeeding, and planning surgery/hysteroscopy for suspected endometriosis or other benign gynaecological condition.  Following consent, participants complete a baseline questionnaire and approval to access imaging.  At surgery, biospecimens and surgeon’s questionnaire are collected.  Post-surgery, surgical and histological reports are collected.  Questionnaires and biospecimen processing steps are adapted from the World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project.

 

In the first 12-months, the JAECE Biobank recruited 97 participants.  We have 95 completed patient surveys and 81 completed surgeon’s surveys.  Fifty-four participants had histology confirmed endometriosis (cases) and 30 were negative on histology (controls) (13 histology reports are pending).  From endometriosis cases we have: 44 bloods, 45 endometrium, 7 myometrium, 27 peritoneal fluids and 97 lesions (from 48 participants).  From non-endometriosis controls we have: 27 bloods, 24 endometrial tissues, 8 myometrial and 16 peritoneal fluids.  The JAECE Biobank is registered with the World Endometriosis Research Foundation.

 

Building a biobank is key to delivering evidence-based clinical research for improved healthcare outcomes for endometriosis patients.  This project demonstrates the successful establishment and 12-month operation of the JAECE Biobank, that aligns with international harmonisation criteria.  Biobanks such as this, will bring us one step closer to improved, collaborative and larger-scale research that builds scientific knowledge.